# Intranasal Human FGF-1 for Subjects With Parkinson's Disease

> **NCT05493462** · PHASE1 · UNKNOWN · sponsor: **Zhittya Genesis Medicine, Inc.** · enrollment: 4 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Human FGF-1

## Key facts

- **NCT ID:** NCT05493462
- **Lead sponsor:** Zhittya Genesis Medicine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 4 (ESTIMATED)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493462, "Intranasal Human FGF-1 for Subjects With Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05493462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*